OPA3 and optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy: For example, pathogenic variants in OPA3 can cause an optic atrophy plus syndrome, characterised by optic atrophy and lower limb spasticity [52].